Belite Bio, Inc (ADR) share price logo

Belite Bio, Inc (ADR)

NASDAQ: BLTE

Mid Cap

$146.12

-2.22

(-1.50%)

as on

Belite Bio, Inc (ADR) Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $144.00
    $151.99
    downward going graph

    1.45%

    Downside

    4.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $56.10
    $200.00
    downward going graph

    61.61%

    Downside

    36.87%

    Upside

    downward going graph

Belite Bio, Inc (ADR) share price movements today

Previous Close
$148.34
Open
$149.00
Volume
368.5K
Day's Low - High
$144.00 - $151.99
52 Week Low - High
$56.10 - $200.00

Belite Bio, Inc (ADR) Historical Returns

1 Month Return
+ 6.42 %
3 Month Return
-5.48 %
1 Year Return
+ 141.6 %
3 Year Return
+ 1090.87 %
5 Year Return
0 %

Belite Bio, Inc (ADR) Stock Fundamentals & Key Indicators

Check Belite Bio, Inc (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.9B

EPS (TTM)

-3.2843

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-101.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-18.93%

Belite Bio, Inc (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Belite Bio, Inc (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$5.9BNANA0.00%NA
BUY$37.1B60.79%69.8712.55%NA
BUY$114.6B139.12%26.835.51%NA
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for Belite Bio, Inc (ADR) Stock including INR - Dollar returns

The Belite Bio, Inc (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Belite Bio, Inc (ADR) investment value today

Current value as on today

₹2,63,171

Returns

₹1,63,171

(+163.17%)

Returns from Belite Bio, Inc (ADR) Stock

₹1,41,601 (+141.6%)

Dollar Impact

₹21,570 (+21.57%)

Analyst Recommendation on Belite Bio, Inc (ADR) Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Belite Bio, Inc (ADR). Average target price of $210.5

Belite Bio, Inc (ADR) Share Price Target

Get share price movements and forecasts by analysts on Belite Bio, Inc (ADR).

What analysts predicted

30.58%UPSIDE

Target Price

$210.5

Current Price

$146.12

Analyzed by

11 Analysts

Target

$210.50

Belite Bio, Inc (ADR) target price $210.5, a slight upside of 30.58% compared to current price of $146.12. According to 11 analysts rating.

Indian Investors' Interest in Belite Bio, Inc (ADR) Stock

Search interest for Belite Bio, Inc (ADR) Stock has increased by 144% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:144% versus previous 30 day period

Belite Bio, Inc (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-6
-10
-10
-9
-11
-15
-17
-23
-28
-32
EBITDA
-6
-9
-
-8
-7
-14
-16
-21
-30
-26
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
0
-
-
-
0
-
Income Before Tax
-6
-9
-9
-8
-10
-14
-16
-21
-25
-26
Income Tax Expense
0
0
-
-
-
-
-
-
-
-
Net Income
-6
-9
-9
-8
-10
-14
-16
-21
-25
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Belite Bio, Inc (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
Operating Income
-5
-9
-12
-31
-39
-84
EBITDA
-5
-9
-12
-31
-35
-77
Interest Expense
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-5
-9
-12
-31
-36
-77
Income Tax Expense
0
0
0
0
0
-
Net Income
-5
-9
-12
-31
-36
-77
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Belite Bio, Inc (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
0
0
0
0
0
-21
0
-26
Operating Cash Flow
-
-
-
-4
-
-
-
0
-
Investing Cash Flow
-
-
-
-
-
-
-
0
-
Financing Cash Flow
-
-
-
39
-
-
-
0
-
Change in Cash
-
-
-
8
-
-
-
0
-

Belite Bio, Inc (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-12
-31
-36
-77
Operating Cash Flow
-7
-11
-29
-29
-36
Investing Cash Flow
0
0
0
-110
-305
Financing Cash Flow
0
36
75
83
663
Change in Cash
-8
24
46
-56
321

Global Institutional Holdings in Belite Bio, Inc (ADR)

Funds
Holdings
Deerfield Management Co
0.76%
BNP Paribas Arbitrage, SA
0.01%
Perceptive Advisors LLC
0.38%
RA Capital Management, LLC
1.08%
Affinity Asset Advisors, LLC
0.16%

Belite Bio, Inc (ADR) News & Key Events

  • img

    Today's Timeline - 01 December

    Mon, 07:44 PM

    -

    Belite Bio announces successful Phase 3 trial results for Tinlarebant, showing significant efficacy in treating Stargardt disease type 1.

    Tue, 02:50 AM

    -

    Belite Bio commences underwritten public offering of American Depositary Shares, subject to market conditions.

    Tue, 09:07 AM

    -

    Belite Bio prices $350 million public offering of American Depositary Shares at $154.00 each.

Insights on Belite Bio, Inc (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BLTE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BLTE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, BLTE stock has moved up by 141.6%

About Belite Bio, Inc (ADR)

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
OrganisationBelite Bio, Inc (ADR)
Headquarters12750 High Bluff Drive, San Diego, CA, United States, 92130
IndustryBiotechnology
CEODr. Yu-Hsin Lin M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Belite Bio, Inc (ADR)

Name

Title

Dr. Yu-Hsin Lin M.B.A., Ph.D.

Chairman of the Board of Directors & CEO

Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.

CFO & Director

Dr. Nathan L. Mata Ph.D.

Chief Scientific Officer

Dr. Hendrik P.N. Scholl M.A., M.D., Ph.D.

Chief Medical Officer

FAQs

What is Belite Bio, Inc (ADR) share price today?

Belite Bio, Inc (ADR) share price today is $146.12 as on at the close of the market. Belite Bio, Inc (ADR) share today touched a day high of $151.99 and a low of $144.

What is the 52 week high and 52 week low for Belite Bio, Inc (ADR) share?

Belite Bio, Inc (ADR) share touched a 52 week high of $200 on and a 52 week low of $56.1 on . Belite Bio, Inc (ADR) stock price today i.e. is closed at $146.12,which is 26.94% down from its 52 week high and 160.46% up from its 52 week low.

What is Belite Bio, Inc (ADR)'s market capitalisation today?

Belite Bio, Inc (ADR) market capitalisation is $0.01T as on .

How to invest in Belite Bio, Inc (ADR) Stock (BLTE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Belite Bio, Inc (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Belite Bio, Inc (ADR) Shares that will get you 0.0103 shares as per Belite Bio, Inc (ADR) share price of $146.12 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Belite Bio, Inc (ADR) Stock (BLTE) from India?

Indian investors can start investing in Belite Bio, Inc (ADR) (BLTE) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Belite Bio, Inc (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Belite Bio, Inc (ADR) share’s latest price of $146.12 as on June 19, 2026 at 8:45 am IST, you will get 0.0684 shares of Belite Bio, Inc (ADR). Learn more about fractional shares .